查看购物车
  • Traditional Chinese
  • English
南美洲和中美洲直接面向消费者的基因测试市场预测至 2030 年 - 区域分析 - 按测试类型、技术和配销通路
市场调查报告书
商品编码
1463706

南美洲和中美洲直接面向消费者的基因测试市场预测至 2030 年 - 区域分析 - 按测试类型、技术和配销通路

South & Central America Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 61 Pages | 订单完成后即时交付

价格

2022年，中南美洲直接面向消费者的基因检测市场价值为8,964万美元，预计2030年将达到3.4985亿美元；预计2022年至2030年CAGR为18.6%。

单核苷酸多态性 (SNP) 晶片的日益普及推动了南美洲和中美洲直接面向消费者的基因检测市场

近年来，随着科学知识的增加，从传统医学向个人化医学的典范稳步转变。这种转变归功于基因工程、单核苷酸多态性 (SNP) 基因分型以及微阵列和生物晶片技术的广泛采用。具有数十万个 SNP 的基因微阵列分析平台的引入将鼓励先进演算法的实施，以更公开地测试个体之间更隐蔽的家谱关係。此外，检测恶性肿瘤的需求也有所增加。在儿科领域，由于无需将 SNP 变异与大规模缺失杂交，週转时间短，因此产生了巨大的需求。因此，随着更多基因异常的检测和治疗，市场预计将会成长。

由于对技术先进和更复杂的 DTC 基因检测的持续需求，高效、准确的 SNP 晶片的需求不断增加。人们对 SNP 晶片的高度偏好可归因于它们能够测量剂量变化和 DNA 多态性，以及对癌症研究至关重要的各种应用，例如 SNP 微阵列分析。此外，对尽量减少 DTC 基因检测错误的需求日益增长，预计将推动 SNP 技术的采用，为市场成长提供机会。

南美洲和中美洲直接面向消费者的基因检测市场概述

南美洲和中美洲直接面向消费者的基因检测市场分为巴西、阿根廷以及南美洲和中美洲其他地区。该地区的市场受到遗传性疾病发病率迅速上升、老年人口不断增长、医疗保健系统的发展以及基因检测意识不断提高等因素的推动。遗传疾病以及慢性病盛行率的上升是推动巴西 DTC 基因检测市场成长的主要因素。例如，遗传性疾病和先天畸形共同构成巴西婴儿死亡的第二大常见原因。对个人化医疗的需求不断增长，疾病诊断新技术的引入，以及行业参与者对开发新诊断技术以提供更快、更准确的结果的关注，预计将成为有利于直接面向消费者的增长的其他值得注意的因素巴西的基因检测市场。随着科学家保证追踪有助于治疗肥胖和糖尿病等现代疾病流行的遗传特征，巴西的医学遗传学领域不断扩大。此外，巴西私人基因检测公司（尤其是提供亲子鑑定解决方案的公司）的数量正在增加。 2019年，巴西领先的基因检测实验室之一GENOMIKA与Veritas签署协议，将后者与预防医学和临床遗传学相关的全基因组和外显子组定序服务纳入其产品组合。

南美洲和中美洲直接面向消费者的基因检测市场收入及 2030 年预测（百万美元）

南美洲和中美洲直接面向消费者的基因检测市场区隔

南美洲和中美洲直接面向消费者的基因检测市场分为测试类型、技术、配销通路和国家。

根据测试类型，南美洲和中美洲直接面向消费者的基因测试市场分为血统测试、预测测试、营养基因组学测试、带因者测试等。 2022 年，血统测验细分市场占据最大份额。

从技术面来看，中南美洲直接面向消费者的基因检测市场分为全基因组定序、单核苷酸多态性晶片、标靶分析等。 2022年，单核苷酸多态性晶片领域占据最大份额。

根据配销通路，南美洲和中美洲直接面向消费者的基因检测市场分为线上和线下。 2022 年，线上细分市场占据了更大的份额。

根据国家/地区，南美洲和中美洲直接面向消费者的基因检测市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲直接面向消费者的基因检测市场占据主导地位。

Ancestry Genomics Inc、Living DNA Ltd、23andMe Inc 和 Genetic Technologies Ltd 是南美洲和中美洲直接面向消费者基因检测市场的一些领先公司。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲直接面向消费者的基因检测市场模式

  • 概述

第 5 章：南美洲和中美洲直接面向消费者的基因检测市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病的发生率不断上升
    • 提高对基因检测潜在益处的认识
  • 市场限制
    • 与直接面向消费者的基因检测相关的高成本和隐私问题
  • 市场机会
    • 单核苷酸多态性 (SNP) 晶片的采用日益广泛
  • 未来的趋势
    • 人们对药物基因学的兴趣日益浓厚，远距医疗的采用也不断增加
  • 影响分析

第 6 章：直接面向消费者的基因检测市场 - 南美洲和中美洲市场分析

  • 概述
  • 南美洲和中美洲直接面向消费者的基因检测市场收入，2022 - 2030

第 7 章：南美洲和中美洲直接面向消费者的基因测试市场 - 收入和 2030 年预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年南美洲和中美洲直接面向消费者的基因测试市场收入份额（按测试类型划分）
  • 血统测试
  • 营养基因组学测试
  • 预测测试
  • 运营商测试
  • 其他的

第 8 章：南美洲和中美洲直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年南美洲和中美洲直接面向消费者的基因检测市场收入份额（按技术划分）
  • 全基因组定序
  • 单核苷酸多态性晶片
  • 针对性分析
  • 其他的

第 9 章：南美洲和中美洲直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按配销通路

  • 概述
  • 2022 年和 2030 年南美洲和中美洲直接面向消费者的基因检测市场收入份额（按配销通路划分）（%）
  • 线上平台
  • 线下平台

第 10 章：南美洲和中美洲直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 国家分析

  • 巴西
  • 阿根廷
  • 余下的

第 11 章：南美洲和中美洲直接面向消费者的基因检测市场-产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：公司简介

  • Ancestry Genomics Inc
  • Living DNA Ltd
  • 23andMe Inc
  • Genetic Technologies Ltd

第 13 章：附录

Product Code: BMIRE00029626

The South & Central America direct-to-consumer genetic testing market was valued at US$ 89.64 million in 2022 and is expected to reach US$ 349.85 million by 2030; it is estimated to grow at a CAGR of 18.6% from 2022 to 2030.

Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips Fuels the South & Central America Direct-to-Consumer Genetic Testing Market

There has been a steady paradigm shift from traditional medicine to personalized medicine with increasing scientific knowledge in recent years. This shift is due to advances in genetic engineering, single nucleotide polymorphism (SNP) genotyping, and the high adoption of microarrays and biochip technologies. The introduction of genetic microarray analysis platforms with hundreds of thousands of SNPs will encourage the implementation of advanced algorithms to test for more secluded genealogical relationships more openly between individuals. In addition, the demand for detecting malignant tumors has also increased. In the pediatric field, the short turnaround time without the need to hybridize SNP variations to massive deletions has led to enormous demand. As a result, the market is expected to grow as more genetic abnormalities are detected and treated.

SNP chips with high efficiency and accuracy are witnessing an increase in demand due to the constant need for technologically advanced and more sophisticated DTC genetic testing. A high preference for SNP chips can be attributed to their ability to measure dosage changes and DNA polymorphism, along with various applications such as the SNP microarray analysis that are vital for cancer research. Furthermore, an increasing need to minimize errors in DTC genetic testing is expected to drive the adoption of SNP technology, thereby providing an opportunity for the market growth.

South & Central America Direct-to-Consumer Genetic Testing Market Overview

The South & Central America direct-to-consumer genetic testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in this region is driven by factors such as the burgeoning incidences of genetic disorders, the growing geriatric population, developments in healthcare systems, and rising awareness about genetic testing. The rising prevalence of the genetic disease, along with chronic illness, is the primary factor driving the growth of Brazil's DTC genetic testing market. For instance, genetic diseases and congenital abnormalities together represent the second most common cause of mortality among infants in Brazil. The growing demand for personalized medicines, introduction of novel technologies in disease diagnosis, and focus of industry players on developing new diagnostic techniques to provide faster results with high accuracy are expected to be other noteworthy factors to favor the growth of the direct-to-consumer genetic testing market in Brazil. The field of medical genetics has expanded in Brazil as scientists assure to track down genetic traits that will help to treat modern disease epidemics, such as obesity and diabetes. Moreover, the number of private genetic testing companies, particularly offering paternity testing solutions, is on the rise in Brazil. In 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, signed an agreement with Veritas to incorporate the latter's Whole Genome and Exome Sequencing services associated with preventive medicine and clinical genetics into its portfolio.

South & Central America Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Direct-to-Consumer Genetic Testing Market Segmentation

The South & Central America direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the South & Central America direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the South & Central America direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the South & Central America direct-to-consumer genetic testing market is bifurcated into online , and offline. The online segment held a larger share in 2022.

Based on country, the South & Central America direct-to-consumer genetic testing market is segmented the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America direct-to-consumer genetic testing market in 2022.

Ancestry Genomics Inc, Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the South & Central America direct-to-consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview

5. South & Central America Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - South & Central America Market Analysis

  • 6.1 Overview
  • 6.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 South & Central America Direct-to-Consumer Genetic Testing Market, By Key Country - Revenue (2022) (US$ Million)
    • 10.1.1 South & Central America Direct-to-Consumer Genetic Testing Market Share by Country - 2022 & 2030, (%)
      • 10.1.1.1 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)

11. South & Central America Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Ancestry Genomics Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Living DNA Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 23andMe Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Genetic Technologies Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Direct-to-Consumer Genetic Testing Market Segmentation
  • Table 2. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Rest of South & Central South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Organic Developments Done by Companies
  • Table 12. Inorganic Developments Done by Companies
  • Table 13. Glossary of Terms, South & Central America Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. South & Central America Direct-to-Consumer Genetic Testing Market Segmentation, By Country
  • Figure 2. South & Central America Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 3. South & Central America Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Ancestry Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Nutrigenomics Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Predictive Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Whole Genome Sequencing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Single Nucleotide Polymorphism Chips: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Targeted Analysis: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 17. Online Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Offline Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America Direct-to-Consumer Genetic Testing Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 20. South & Central America Direct-to-Consumer Genetic Testing Market Share by Country - 2022 & 2030, (%)
  • Figure 21. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)